$SYBX Cashflow Statement | Understand Stock

$SYBX

$0.56 +$0.00 (0.0%) Close

$SYBX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Gain on disposal of property and equipment
Impairment loss on fixed assets
Impairment loss on ROU assets
Gain on lease termination
Impairment of prepaid research and development
Equity-based compensation expense
Change in fair value warrant liability
Transaction costs allocated to warrant liabilities
Accretion/amortization of investment securities
Reduction in carrying amount of operating lease right of use asset
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Prepaid research and development, net of current portion
Accounts payable and accrued expenses
Deferred revenue
Operating lease liabilities
Other long-term liabilities
Other assets

Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities
Proceeds from maturity of marketable securities
Proceeds from redemption of marketable securities
Purchases of property and equipment
Proceeds from the sale of property and equipment
Net cash provided by investing activities

Cash flows from financing activities:
Payments on finance lease obligations
Restricted stock awards withheld for payment of employees' withholding tax liability
Proceeds from issuance of common stock, net of issuance costs
At-the-market Offering
Total proceeds from issuance of common stock, net of issuance costs

Proceeds from employee stock purchases and exercise of stock options
Proceeds from issuance of common stock, pre-funded warrants and purchase warrants, net of issuance costs
Proceeds from exercise of warrants
Repurchase of Common Stock (Treasury Stock)
Net cash provided by financing activities

Net decrease increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of non-cash investing activities:
Decrease in right-of-use asset and operating lease liabilities due to lease termination
Assets acquired under operating lease obligation
Property and equipment sales included in other current assets
Property and equipment purchases included in accounts payable and accrued expenses
Supplemental disclosure of non-cash financing activities:
Purchase under finance lease
Cash paid for income taxes
Cash paid for interest
Issuance costs included in accounts payable and accrued expenses

Comments